Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury

Anna Junk, Antonios Mammis, Sean I. Savitz, Manjeet Singh, Steven Roth, Samit Malhotra, Pearl S. Rosenbaum, Anthony Cerami, Michael Brines, Daniel M. Rosenbaum

Research output: Contribution to journalArticle

380 Citations (Scopus)

Abstract

Erythropoietin (EPO) plays an important role in the brain's response to neuronal injury. Systemic administration of recombinant human EPO (rhEPO) protects neurons from injury after middle cerebral artery occlusion, traumatic brain injury, neuroinflammation, and excitotoxicity. Protection is in part mediated by antiapoptotic mechanisms. We conducted parallel studies of rhEPO in a model of transient global retinal ischemia induced by raising intraocular pressure, which is a clinically relevant model for retinal diseases. We observed abundant expression of EPO receptor (EPO-R) throughout the ischemic retina. Neutralization of endogenous EPO with soluble EPO-R exacerbated ischemic injury, which supports a crucial role for an endogenous EPO/EPO-R system in the survival and recovery of neurons after an ischemic insult. Systemic administration of rhEPO before or immediately after retinal ischemia not only reduced histopathological damage but also promoted functional recovery as assessed by electroretinography. Exogenous EPO also significantly diminished terminal deoxynucleotidyltransferase-mediated dUTP end labeling labeling of neurons in the ischemic retina, implying an antiapoptotic mechanism of action. These results further establish EPO as a neuroprotective agent in acute neuronal ischemic injury.

Original languageEnglish
Pages (from-to)10659-10664
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume99
Issue number16
DOIs
StatePublished - Aug 1 2002
Externally publishedYes

Fingerprint

Retinal Neurons
Erythropoietin
Reperfusion Injury
Wounds and Injuries
Neurons
Retina
Ischemia
Erythropoietin Receptors
Electroretinography
Retinal Diseases
DNA Nucleotidylexotransferase
Middle Cerebral Artery Infarction
Neuroprotective Agents
Intraocular Pressure
Survival
Brain

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. / Junk, Anna; Mammis, Antonios; Savitz, Sean I.; Singh, Manjeet; Roth, Steven; Malhotra, Samit; Rosenbaum, Pearl S.; Cerami, Anthony; Brines, Michael; Rosenbaum, Daniel M.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, No. 16, 01.08.2002, p. 10659-10664.

Research output: Contribution to journalArticle

Junk, A, Mammis, A, Savitz, SI, Singh, M, Roth, S, Malhotra, S, Rosenbaum, PS, Cerami, A, Brines, M & Rosenbaum, DM 2002, 'Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury', Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 16, pp. 10659-10664. https://doi.org/10.1073/pnas.152321399
Junk, Anna ; Mammis, Antonios ; Savitz, Sean I. ; Singh, Manjeet ; Roth, Steven ; Malhotra, Samit ; Rosenbaum, Pearl S. ; Cerami, Anthony ; Brines, Michael ; Rosenbaum, Daniel M. / Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. In: Proceedings of the National Academy of Sciences of the United States of America. 2002 ; Vol. 99, No. 16. pp. 10659-10664.
@article{22ae513a67404a9ca4c30b46cb5654bd,
title = "Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury",
abstract = "Erythropoietin (EPO) plays an important role in the brain's response to neuronal injury. Systemic administration of recombinant human EPO (rhEPO) protects neurons from injury after middle cerebral artery occlusion, traumatic brain injury, neuroinflammation, and excitotoxicity. Protection is in part mediated by antiapoptotic mechanisms. We conducted parallel studies of rhEPO in a model of transient global retinal ischemia induced by raising intraocular pressure, which is a clinically relevant model for retinal diseases. We observed abundant expression of EPO receptor (EPO-R) throughout the ischemic retina. Neutralization of endogenous EPO with soluble EPO-R exacerbated ischemic injury, which supports a crucial role for an endogenous EPO/EPO-R system in the survival and recovery of neurons after an ischemic insult. Systemic administration of rhEPO before or immediately after retinal ischemia not only reduced histopathological damage but also promoted functional recovery as assessed by electroretinography. Exogenous EPO also significantly diminished terminal deoxynucleotidyltransferase-mediated dUTP end labeling labeling of neurons in the ischemic retina, implying an antiapoptotic mechanism of action. These results further establish EPO as a neuroprotective agent in acute neuronal ischemic injury.",
author = "Anna Junk and Antonios Mammis and Savitz, {Sean I.} and Manjeet Singh and Steven Roth and Samit Malhotra and Rosenbaum, {Pearl S.} and Anthony Cerami and Michael Brines and Rosenbaum, {Daniel M.}",
year = "2002",
month = "8",
day = "1",
doi = "10.1073/pnas.152321399",
language = "English",
volume = "99",
pages = "10659--10664",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "16",

}

TY - JOUR

T1 - Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury

AU - Junk, Anna

AU - Mammis, Antonios

AU - Savitz, Sean I.

AU - Singh, Manjeet

AU - Roth, Steven

AU - Malhotra, Samit

AU - Rosenbaum, Pearl S.

AU - Cerami, Anthony

AU - Brines, Michael

AU - Rosenbaum, Daniel M.

PY - 2002/8/1

Y1 - 2002/8/1

N2 - Erythropoietin (EPO) plays an important role in the brain's response to neuronal injury. Systemic administration of recombinant human EPO (rhEPO) protects neurons from injury after middle cerebral artery occlusion, traumatic brain injury, neuroinflammation, and excitotoxicity. Protection is in part mediated by antiapoptotic mechanisms. We conducted parallel studies of rhEPO in a model of transient global retinal ischemia induced by raising intraocular pressure, which is a clinically relevant model for retinal diseases. We observed abundant expression of EPO receptor (EPO-R) throughout the ischemic retina. Neutralization of endogenous EPO with soluble EPO-R exacerbated ischemic injury, which supports a crucial role for an endogenous EPO/EPO-R system in the survival and recovery of neurons after an ischemic insult. Systemic administration of rhEPO before or immediately after retinal ischemia not only reduced histopathological damage but also promoted functional recovery as assessed by electroretinography. Exogenous EPO also significantly diminished terminal deoxynucleotidyltransferase-mediated dUTP end labeling labeling of neurons in the ischemic retina, implying an antiapoptotic mechanism of action. These results further establish EPO as a neuroprotective agent in acute neuronal ischemic injury.

AB - Erythropoietin (EPO) plays an important role in the brain's response to neuronal injury. Systemic administration of recombinant human EPO (rhEPO) protects neurons from injury after middle cerebral artery occlusion, traumatic brain injury, neuroinflammation, and excitotoxicity. Protection is in part mediated by antiapoptotic mechanisms. We conducted parallel studies of rhEPO in a model of transient global retinal ischemia induced by raising intraocular pressure, which is a clinically relevant model for retinal diseases. We observed abundant expression of EPO receptor (EPO-R) throughout the ischemic retina. Neutralization of endogenous EPO with soluble EPO-R exacerbated ischemic injury, which supports a crucial role for an endogenous EPO/EPO-R system in the survival and recovery of neurons after an ischemic insult. Systemic administration of rhEPO before or immediately after retinal ischemia not only reduced histopathological damage but also promoted functional recovery as assessed by electroretinography. Exogenous EPO also significantly diminished terminal deoxynucleotidyltransferase-mediated dUTP end labeling labeling of neurons in the ischemic retina, implying an antiapoptotic mechanism of action. These results further establish EPO as a neuroprotective agent in acute neuronal ischemic injury.

UR - http://www.scopus.com/inward/record.url?scp=0036678821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036678821&partnerID=8YFLogxK

U2 - 10.1073/pnas.152321399

DO - 10.1073/pnas.152321399

M3 - Article

VL - 99

SP - 10659

EP - 10664

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 16

ER -